Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 283 participants.
Also called NCT05257148
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 283 participants
- Registry
-
NCT05257148 -
2020-002340-23
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT05257148. Non-randomized; no masking; primary purpose treatment. Start 2021-05-26 (actual); primary completion 2021-12-22 (actual). Results posted on 2024-09-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy
- Acronym
- Masaccio
- Condition
- Hypertension
- Intervention (Drug)
- Zofenopril 30 mg
- Intervention (Drug)
- Nebivolol 5 mg
- Intervention (Drug)
- Zofenopril 30 mg + Nebivolol 5 mg
- Lead sponsor
- Menarini International Operations Luxembourg SA
Record details
- Record id
cardio:ct-nct05257148- Content hash
4220b53e1bc270b467bb7dd7edb886e86caefe0308137bbe1ef5c10f8c21d567